Paul J Hastings
CIK 1309702 · View on SEC EDGAR ↗
First SEC filing: July 9, 2020 · Latest: July 9, 2020
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 18, 2026 | NKTX | S | 1,776 | $2.71 | $4,813 | 390,247 Direct | -0.45% | Disposed | -6.3% (price as of 2026-08-21) |
| Jan. 15, 2026 | NKTX | S | 26,046 | $2.07 | $53,915 | 390,023 Direct | -6.26% | Disposed | 22.6% (price as of 2026-08-21) |
| June 18, 2025 | NKTX | S | 1,790 | $1.79 | $3,204 | 320,069 Direct | -0.56% | Disposed | 41.8% (price as of 2026-08-21) |
| Jan. 15, 2025 | NKTX | S | 17,378 | $2.20 | $38,232 | 319,859 Direct | -5.15% | Disposed | 15.4% (price as of 2026-08-21) |
| June 18, 2024 | NKTX | S | 1,770 | $5.60 | $9,912 | 240,737 Direct | -0.73% | Disposed | -54.7% (price as of 2026-08-21) |
| June 13, 2024 | PCRX | S 10b5-1 | 880 | $28.38 | $24,974 | 12,724 Direct | -6.47% | Disposed | -15.5% (price as of 2026-08-21) |
| Jan. 16, 2024 | NKTX | S | 9,697 | $8.74 | $84,752 | 390,507 Direct | -2.42% | Disposed | -71.0% (price as of 2026-08-21) |
| June 20, 2023 | NKTX | S | 1,704 | $4.85 | $8,264 | 313,402 Direct | -0.54% | Disposed | -47.7% (price as of 2026-08-21) |
| June 5, 2023 | PCRX | S | 580 | $38.34 | $22,237 | 6,599 Direct | -8.08% | Disposed | -37.4% (price as of 2026-08-21) |
| May 15, 2023 | PCRX | S 10b5-1 | 7,000 | $41.85 | $292,950 | 7,179 Direct | -49.37% | Disposed | -42.7% (price as of 2026-08-21) |
| Jan. 17, 2023 | NKTX | S | 3,691 | $5.49 | $20,264 | 313,106 Direct | -1.17% | Disposed | -53.8% (price as of 2026-08-21) |
| Sept. 29, 2022 | NKTX | S 10b5-1 | 498 | $13.00 | $6,474 | 250,461 Direct | -0.20% | Disposed | -80.5% (price as of 2026-08-21) |
| Sept. 28, 2022 | NKTX | S 10b5-1 | 23,376 | $13.03 | $304,589 | 250,959 Direct | -8.52% | Disposed | -80.5% (price as of 2026-08-21) |
| Sept. 21, 2022 | NKTX | S 10b5-1 | 6,126 | $13.01 | $79,699 | 274,335 Direct | -2.18% | Disposed | -80.5% (price as of 2026-08-21) |
| July 11, 2022 | PCRX | S 10b5-1 | 533 | $56.95 | $30,354 | 7,179 Direct | -6.91% | Disposed | -57.9% (price as of 2026-08-21) |
| Sept. 29, 2021 | NKTX | S 10b5-1 | 223 | $26.53 | $5,916 | 219,061 Direct | -0.10% | Disposed | -90.4% (price as of 2026-08-21) |
| Sept. 29, 2021 | NKTX | S 10b5-1 | 8,277 | $27.20 | $225,134 | 219,284 Direct | -3.64% | Disposed | -90.7% (price as of 2026-08-21) |
| June 21, 2021 | NKTX | S 10b5-1 | 4,693 | $26.39 | $123,848 | 231,368 Direct | -1.99% | Disposed | -90.4% (price as of 2026-08-21) |
| June 21, 2021 | NKTX | S 10b5-1 | 3,807 | $26.89 | $102,370 | 227,561 Direct | -1.65% | Disposed | -90.6% (price as of 2026-08-21) |
| June 4, 2021 | PCRX | S 10b5-1 | 630 | $62.19 | $39,180 | 5,486 Direct | -10.30% | Disposed | -61.4% (price as of 2026-08-21) |
| March 30, 2021 | NKTX | S 10b5-1 | 3,130 | $32.21 | $100,817 | 236,061 Direct | -1.31% | Disposed | -92.1% (price as of 2026-08-21) |
| March 30, 2021 | NKTX | S 10b5-1 | 2,409 | $31.24 | $75,257 | 239,191 Direct | -1.00% | Disposed | -91.9% (price as of 2026-08-21) |
| March 30, 2021 | NKTX | S 10b5-1 | 11,461 | $30.23 | $346,466 | 241,600 Direct | -4.53% | Disposed | -91.6% (price as of 2026-08-21) |
| March 5, 2021 | PCRX | S | 3,000 | $65.88 | $197,640 | 6,116 Direct | -32.91% | Disposed | -63.6% (price as of 2026-08-21) |
| June 4, 2020 | PCRX | S | 2,025 | $47.46 | $96,106 | 4,856 Direct | -29.43% | Disposed | -49.5% (price as of 2026-08-21) |
| June 4, 2019 | PCRX | S 10b5-1 | 782 | $42.66 | $33,360 | 2,747 Direct | -22.16% | Disposed | -43.8% (price as of 2026-08-21) |
| June 4, 2018 | PCRX | S | 771 | $33.90 | $26,137 | 2,747 Direct | -21.92% | Disposed | -29.2% (price as of 2026-08-21) |
| Aug. 22, 2017 | PCRX | S | 1,044 | $36.15 | $37,741 | 3,518 Direct | -22.88% | Disposed | -33.6% (price as of 2026-08-21) |
| June 6, 2016 | PCRX | S 10b5-1 | 1,136 | $46.95 | $53,335 | 1,717 Direct | -39.82% | Disposed | -48.9% (price as of 2026-08-21) |
| Feb. 17, 2016 | PCRX | S 10b5-1 | 3,000 | $60.00 | $180,000 | 2,853 Direct | -51.26% | Disposed | -60.0% (price as of 2026-08-21) |
| Nov. 20, 2015 | PCRX | S 10b5-1 | 3,000 | $60.00 | $180,000 | 2,853 Direct | -51.26% | Disposed | -60.0% (price as of 2026-08-21) |
| Aug. 17, 2015 | PCRX | S 10b5-1 | 3,000 | $60.02 | $180,060 | 2,853 Direct | -51.26% | Disposed | -60.0% (price as of 2026-08-21) |
| April 10, 2015 | PCRX | S 10b5-1 | 2,500 | $88.00 | $220,000 | 853 Direct | -74.56% | Disposed | -72.7% (price as of 2026-08-21) |
| Jan. 12, 2015 | PCRX | S 10b5-1 | 2,500 | $94.06 | $235,150 | 853 Direct | -74.56% | Disposed | -74.5% (price as of 2026-08-21) |
| Oct. 10, 2014 | PCRX | S 10b5-1 | 2,500 | $94.87 | $237,175 | 853 Direct | -74.56% | Disposed | -74.7% (price as of 2026-08-21) |
| July 10, 2014 | PCRX | S 10b5-1 | 698 | $85.96 | $60,000 | 853 Direct | -45.00% | Disposed | -72.1% (price as of 2026-08-21) |
| July 10, 2014 | PCRX | S 10b5-1 | 502 | $85.03 | $42,685 | 1,551 Direct | -24.45% | Disposed | -71.8% (price as of 2026-08-21) |
| July 10, 2014 | PCRX | S 10b5-1 | 700 | $84.08 | $58,856 | 2,053 Direct | -25.43% | Disposed | -71.5% (price as of 2026-08-21) |
Showing latest 100 of 107 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 16, 2026 | ENGNW | Stock Option (Right to Buy) | Common Shares (31,000) | $1.75 | June 16, 2036 | 31,000 | Acquired |
| Jan. 6, 2026 | NKTX | Stock Option (right to buy) | Common Stock (562,000) | $1.93 | Jan. 5, 2036 | 562,000 | Acquired |
| June 16, 2025 | ENGNW | Stock Option (Right to Buy) | Common Shares (22,500) | $3.31 | June 16, 2035 | 22,500 | Acquired |
| June 5, 2025 | NKTX | Stock Option (right to buy) | Common Stock (377,000) | $1.83 | June 5, 2035 | 377,000 | Acquired |
| Jan. 3, 2025 | NKTX | Stock Option (right to buy) | Common Stock (565,500) | $2.50 | Jan. 2, 2035 | 565,500 | Acquired |
| June 15, 2024 | ENGNW | Stock Option (Right to Buy) | Common Shares (40,000) | $9.00 | June 15, 2034 | 40,000 | Acquired |
| June 12, 2024 | PCRX | Stock Option (Right to Buy) | Common Stock (12,179) | $28.68 | June 12, 2034 | 12,179 | Acquired |
| Jan. 4, 2024 | NKTX | Stock Option (right to buy) | Common Stock (509,500) | $6.01 | Jan. 3, 2034 | 509,500 | Acquired |
| June 14, 2023 | PCRX | Stock Option (Right to Buy) | Common Stock (12,925) | $38.74 | June 14, 2033 | 12,925 | Acquired |
| May 15, 2023 | PCRX | Stock Option (Right to Buy) | Common Stock (7,000) | $29.90 | June 12, 2023 | 7,000 | Disposed |
| Jan. 13, 2023 | NKTX | Stock Option (right to buy) | Common Stock (386,500) | $5.57 | Jan. 12, 2033 | 386,500 | Acquired |
| June 17, 2022 | NKTX | Stock Option (right to buy) | Common Stock (120,000) | $12.25 | June 16, 2032 | 120,000 | Acquired |
| June 8, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (8,225) | $59.39 | June 8, 2032 | 8,225 | Acquired |
| Jan. 14, 2022 | NKTX | Stock Option (right to buy) | Common Stock (251,100) | $12.14 | Jan. 13, 2032 | 251,100 | Acquired |
| June 9, 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (7,626) | $60.96 | June 9, 2031 | 7,626 | Acquired |
| March 5, 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (3,000) | $13.98 | June 2, 2021 | 3,000 | Disposed |
| Jan. 8, 2021 | NKTX | Stock Option (right to buy) | Common Stock (157,500) | $54.89 | Jan. 7, 2031 | 157,500 | Acquired |
| July 9, 2020 | NKTX | Stock Option (right to buy) | Common Stock (202,400) | $18.00 | July 8, 2030 | 202,400 | Acquired |
| June 9, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (8,027) | $47.65 | June 9, 2030 | 8,027 | Acquired |
| June 5, 2019 | PCRX | Stock Option (Right to Buy) | Common Stock (8,437) | $43.54 | June 5, 2029 | 8,437 | Acquired |
| June 13, 2018 | PCRX | Stock Option (Right to Buy) | Common Stock (4,693) | $38.35 | June 13, 2028 | 4,693 | Acquired |
| June 8, 2018 | TARA | Stock Option (Right to Buy) | Common Stock (12,700) | $2.50 | June 7, 2028 | 12,700 | Acquired |
| June 20, 2017 | TARA | Stock Option (Right to Buy) | Common Stock, $0.001 par value (6,666) | $1.30 | June 19, 2027 | 6,666 | Acquired |
| June 14, 2017 | PCRX | Stock Option (Right to Buy) | Common Stock (2,714) | $44.20 | June 14, 2027 | 2,714 | Acquired |
| Oct. 18, 2016 | TARA | Stock Option (Right to Buy) | Common Stock, $0.001 par value (13,333) | $9.00 | Oct. 17, 2026 | 13,333 | Acquired |
| June 15, 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (2,975) | $40.34 | June 15, 2026 | 2,975 | Acquired |
| Feb. 17, 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (1,000) | $10.81 | June 4, 2022 | 1,000 | Disposed |
| Feb. 17, 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (2,000) | $13.98 | June 2, 2021 | 2,000 | Disposed |
| Nov. 20, 2015 | PCRX | Stock Option (Right to Buy) | Common Stock (3,000) | $10.81 | June 4, 2022 | 3,000 | Disposed |
| Aug. 17, 2015 | PCRX | Stock Option (Right to Buy) | Common Stock (3,000) | $10.81 | June 4, 2022 | 3,000 | Disposed |
| June 3, 2015 | PCRX | Stock Option (Right to Buy) | Common Stock (4,000) | $79.43 | June 3, 2025 | 4,000 | Acquired |
| April 10, 2015 | PCRX | Stock Option (Right to Buy) | Common Stock (2,500) | $13.98 | June 2, 2021 | 2,500 | Disposed |
| Jan. 12, 2015 | PCRX | Stock Option (Right to Buy) | Common Stock (2,500) | $13.98 | June 2, 2021 | 2,500 | Disposed |
| Oct. 10, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (2,500) | $13.98 | June 2, 2021 | 2,500 | Disposed |
| July 10, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (2,500) | $13.98 | June 2, 2021 | 2,500 | Disposed |
| June 3, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (8,000) | $81.00 | June 3, 2024 | 8,000 | Acquired |
| June 12, 2013 | PCRX | Stock Option (Right to Buy) | Common Stock (7,000) | $29.20 | June 11, 2023 | 7,000 | Acquired |
| June 5, 2012 | PCRX | Common Stock | Common Stock (7,000) | $10.81 | June 4, 2022 | 7,000 | Acquired |
| June 2, 2011 | PCRX | Stock option (right to buy) | Common Stock (15,000) | $13.98 | June 2, 2021 | 15,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 5 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 9, 2020 | NKTX | Common Stock | 253,061 | Direct |
| July 9, 2020 | NKTX | Stock Option (right to buy)→ Common Stock | — | Direct |
| July 9, 2020 | NKTX | Stock Option (right to buy)→ Common Stock | — | Direct |
| Oct. 20, 2016 | TARA | Common Stock, $0.001 par value | 6,636 | Indirect |
| June 6, 2011 | PCRX | Common Stock | 0 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
NKTX
CEO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $674,384 | — | $236,250 | $1,711,957 | $344,947 | — | $10,500 | $2,978,038 |
| 2024 | $648,446 | — | $510,850 | $2,494,818 | $320,981 | — | $10,350 | $3,985,445 |
| 2022 | $599,525 | — | $747,541 | $3,058,795 | $329,739 | — | $9,150 | $4,744,750 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.